Skip to main content

. 1982 Dec 4;285(6355):1618–1619. doi: 10.1136/bmj.285.6355.1618

Neurofibromatosis, phaeochromocytoma, and somatostatinoma.

A M Cantor, C C Rigby, P R Beck, D Mangion

PMCID: PMC1500802 PMID: 6128052

1618

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Krejs G. J., Orci L., Conlon J. M., Ravazzola M., Davis G. R., Raskin P., Collins S. M., McCarthy D. M., Baetens D., Rubenstein A. Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med. 1979 Aug 9;301(6):285–292. doi: 10.1056/NEJM197908093010601. [DOI] [PubMed] [Google Scholar]
Larsson L. I., Hirsch M. A., Holst J. J., Ingemansson S., Kühl C., Jensen S. L., Lundqvist G., Rehfeld J. F., Schwartz T. W. Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet. 1977 Mar 26;1(8013):666–668. doi: 10.1016/s0140-6736(77)92113-4. [DOI] [PubMed] [Google Scholar]
Penman E., Wass J. A., Lund A., Lowry P. J., Stewart J., Dawson A. M., Besser G. M., Rees L. H. Development and validation of a specific radioimmunoassay for somatostatin in human plasma. Ann Clin Biochem. 1979 Jan;16(1):15–25. doi: 10.1177/000456327901600103. [DOI] [PubMed] [Google Scholar]
Wright J., Abolfathi A., Penman E., Marks V. Pancreatic somatostatinoma presenting with hypoglycaemia. Clin Endocrinol (Oxf) 1980 Jun;12(6):603–608. doi: 10.1111/j.1365-2265.1980.tb01382.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES